Specifically, the intronic LHCGR variant rs4073366 (lhcgr2) was found to markedly reduce AD risk among APOE ε4 carriers, effectively reversing the increased risk typically conferred by APOE ε4 (Haasl et al., 2008). The gene discussed is APOE; the disease is Alzheimer disease.